InvestSMART

Rhythm Biosciences Limited (ASX: RHY) - Announcements

- Current share price for RHY : $0.081

ASX company news and announcements for Rhythm Biosciences Limited (RHY) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Rhythm Biosciences Limited (RHY) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Rhythm Biosciences Limited (RHY), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Rhythm Biosciences Limited (RHY)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$29 Rhythm signs Alfred Hospital for ColoSTAT clinical trial 26 Jun 2019 9:43AM $0.165 $0.081 fallen by 50.91%
$29 Monash Health signed with first patients recruited 18 Jun 2019 9:16AM $0.150 $0.081 fallen by 46%
$29 Rhythm Biosciences receives ISO certification 22 May 2019 8:27AM $0.175 $0.081 fallen by 53.71%
$29 Appendix 4C - quarterly 30 Apr 2019 9:11AM $0.200 $0.081 fallen by 59.50%
$29 Rhythm recruits first patient in ColoSTAT clinical trial 18 Mar 2019 9:45AM $0.175 $0.081 fallen by 53.71%
$29 Appendix 4D and Half Yearly Report and Accounts 26 Feb 2019 11:58AM $0.145 $0.081 fallen by 44.14%
$29 RHY Signs first ColoSTAT site for Clinical Trial - Study 7 20 Feb 2019 8:37AM $0.150 $0.081 fallen by 46%
$29 Corporate Presentation 11 Feb 2019 8:56AM $0.145 $0.081 fallen by 44.14%
$29 Rhythm secures ethics approval for ColoSTAT clinical trial 8 Feb 2019 9:57AM $0.130 $0.081 fallen by 37.69%
$29 Appendix 4C 29 Jan 2019 9:55AM $0.135 $0.081 fallen by 40%
$29 RHY Welcomes Australian Government's $10m Investment 23 Jan 2019 11:42AM $0.135 $0.081 fallen by 40%
$29 Rhythm Receives R&D Tax Incentive Refund 11 Dec 2018 10:00AM $0.135 $0.081 fallen by 40%
$29 Rhythm Completes Reagent Development Program 5 Dec 2018 9:04AM $0.150 $0.081 fallen by 46%
$29 Appointment of CEO - Senior Management Changes 28 Nov 2018 8:51AM $0.160 $0.081 fallen by 49.38%
$29 Results of Meeting 26 Nov 2018 11:47AM $0.170 $0.081 fallen by 52.35%
$29 AGM Presentation 26 Nov 2018 9:53AM $0.150 $0.081 fallen by 46%
$29 Change of Director's Interest Notice 14 Nov 2018 8:36AM $0.165 $0.081 fallen by 50.91%
$29 Appendix 4C 29 Oct 2018 2:28PM $0.165 $0.081 fallen by 50.91%
$29 Notice of Annual General Meeting/Proxy Form 12 Oct 2018 4:21PM $0.145 $0.081 fallen by 44.14%
$29 Final Antibody Selection Complete 3 Oct 2018 9:32AM $0.150 $0.081 fallen by 46%
$29 Appendix 4G and Corporate Governance Statement 31 Aug 2018 11:39AM $0.130 $0.081 fallen by 37.69%
$29 Annual Report 31 Aug 2018 11:35AM $0.130 $0.081 fallen by 37.69%
$29 Appendix 4E 31 Aug 2018 11:25AM $0.130 $0.081 fallen by 37.69%
$29 Appendix 3B - release from escrow 29 Aug 2018 4:09PM $0.145 $0.081 fallen by 44.14%
$29 Change in substantial holding 13 Aug 2018 12:25PM $0.145 $0.081 fallen by 44.14%

576 - 600 of 639 results

Page 24 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.